A randomized trial of educational materials, pillboxes, and mailings to improve adherence with antiretroviral therapy in an Inner City HIV clinic

Journal of Clinical Outcomes Management

Volumn 13, Issue 4, 2006, Pages 217-221

  Levin, Todd R ^a,b   Klibanov, Olga M ^a,b   Axelrod, Peter ^a,b   van der Berg Wolf, Mary ^a,b   Finley, Gloria L ^a,b   Gray, Anastasia ^a,b   Holdsworth, Catherine ^a,b   Moyer, Darilyn V ^a,b   Tedaldi, Ellen M ^a,b   Samuel, Rafik ^a,b,c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COCAINE; DIAMORPHINE; ILLICIT DRUG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ALCOHOL ABUSE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; DRUG USE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MEDICAL DOCUMENTATION; MOTIVATION; OUTCOMES RESEARCH; OUTPATIENT CARE; PATIENT COMPLIANCE; POSTAL MAIL; PREDICTION; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; URBAN AREA; VIRUS LOAD;

EID: 33748741994     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
2. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection [published erratum appears in Ann Intern Med 2002;136:253]. Ann Intern Med 2000;133:21-30.
3. Sethi AK, Celentano DD, Gange SJ, et al. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 2003;37:1112-8.
4. Garcia de Olalla P, Knobel H, Carmona A, et al. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr 2002;30:105-10.
5. Wood E, Hogg RS, Yip B, et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Ann Intern Med 2003;139:810-6.
6. Hugen PW, Langebeek N, Burger DM, et al. Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electric monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr 2002;30:324-34.
7. Melbourne KM, Geletko SM, Brown SL, et al. Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Read 1999,9:329-38.
8. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors [published erratum appears in Ann Intern Med 2002;136:175]. Ann Intern Med 2001;134:968-77.
9. Walsh JC, Mandalia S, Gazzard BG. Response to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS 2002;16:269-277.
10. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-66.
11. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000;30 Suppl 2:S171-6.
12. Reynolds NR. Initiatives to promote adherence in HIV-infected patients. AIDS Read 1999;9:53-6.
13. Andrews L, Friedland G. Progress in HIV therapeutics and the challenges of adherence to antiretroviral therapy. Infect Dis Clin North Am 2000;14:901-28.
14. Miller LG, Hays RD. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. AIDS Read 2000;10:177-85.
15. Miller LG, Liu H, Hays RD, et al. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis 2003;36:514-8.
16. Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis 2001;33:865-72.
17. Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr 2002;29 Suppl 1:S2-10.
18. Tuldra A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2000;25:221-8.
19. Nokes KM, Lee C, and Altman C. Using a telephone support group for HIV-positive persons aged 50+ to increase social support and health related knowledge. In: Laurence J, editor. Medication adherence in HIV/ AIDS. Larchmont (NY): Mary Ann Liebert, Inc.;2004:367-73.
20. Magnus M, Schmidt, Kirkhart, et al. Association between ancillary services and clinical and behavioral outcomes among HIV-infected women. In: Laurence J, editor. Medication adherence in HIV/AIDS. Larchmont (NY): Mary Ann Liebert, Inc.;2004:385-93.
21. McNabb JJ, Nicolau DP, Stoner JA, Ross J. Patterns of adherence to antiretroviral medications: the value of electronic monitoring. AIDS 2003;17:1763-7.
22. Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 2002;16:767-74.
23. Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med 1999;14:267-73.
24. Mohammed H, Kieltyka L, Richardson-Alston G, et al. Adherence to HAART among HIV-infected persons in rural Louisiana. AIDS Patient Care STDS 2004;18:289-96.